Document Detail


Sublingual versus vaginal misoprostol for induction of labor at term: a randomized prospective placebo-controlled study.
MedLine Citation:
PMID:  20144171     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To assess the effectiveness and safety of sublingual misoprostol (50 microg), compared with the same dose administered vaginally every 6 h for cervical ripening and labor induction in women with a viable fetus in the third trimester of pregnancy.
METHODS: This double-blind randomized prospective placebo-controlled trial included 480 women with medical or obstetric indications for labor induction and undilated, uneffaced cervices. The patients were assigned randomly to receive 50 microg of sublingual or 50 microg of vaginal misoprostol every 6 h for 24 h. Maternal and neonatal outcome were analyzed.
RESULTS: A total of 169 (70.4%) patients delivered vaginally in the sublingual group compared to 160 (66.7%) in the vaginal group. The main indications for cesarean section in both groups were fetal distress (33/71 [46.4%] vs 38/80 [47.5%]), followed by failure of labor progress. Thirty three (13.8%) patients in the sublingual group had meconium staining of the amniotic fluid compared to 39 (16.3%) in the vaginal group. There was no difference between the groups regarding the induction-to-delivery interval, duration of labor, neonatal outcome or maternal side-effects.
CONCLUSION: Sublingual misoprostol is as effective as vaginal misoprostol for induction of labor at term. Moreover, the sublingual route is associated with a significantly higher patient satisfaction rate than vaginal misoprostol.
Authors:
Kamal M Zahran; Ahmed Y Shahin; Mohamad S Abdellah; Khalid I Elsayh
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The journal of obstetrics and gynaecology research     Volume:  35     ISSN:  1447-0756     ISO Abbreviation:  J. Obstet. Gynaecol. Res.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-02-10     Completed Date:  2010-05-25     Revised Date:  2012-01-19    
Medline Journal Info:
Nlm Unique ID:  9612761     Medline TA:  J Obstet Gynaecol Res     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  1054-60     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Women's Health Centre, Faculty of Medicine, Assiut University, Assuit, Egypt. drzahranmk@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intravaginal
Administration, Sublingual
Adult
Cervical Ripening / drug effects*
Chi-Square Distribution
Double-Blind Method
Female
Humans
Infant, Newborn
Labor, Induced / methods*
Misoprostol / administration & dosage*
Oxytocics / administration & dosage*
Patient Satisfaction
Pregnancy
Prospective Studies
Chemical
Reg. No./Substance:
0/Oxytocics; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum prolidase activity and oxidative stress markers in pregnancies with intrauterine growth restri...
Next Document:  Thrombophilia investigation in Malaysian women with recurrent pregnancy loss.